ARTV
Price
$7.03
Change
+$0.16 (+2.33%)
Updated
Jun 3, 01:02 PM (EDT)
Capitalization
333.8M
85 days until earnings call
Intraday BUY SELL Signals
AURA
Price
$6.84
Change
-$0.06 (-0.87%)
Updated
Jun 3, 02:54 PM (EDT)
Capitalization
743.35M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs AURA

Header iconARTV vs AURA Comparison
Open Charts ARTV vs AURABanner chart's image
ARTV vs AURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARTV vs. AURA commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and AURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (ARTV: $6.87 vs. AURA: $6.91)
Brand notoriety: ARTV and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 118% vs. AURA: 86%
Market capitalization -- ARTV: $333.8M vs. AURA: $743.35M
ARTV [@Biotechnology] is valued at $333.8M. AURA’s [@Biotechnology] market capitalization is $743.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 0 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ARTV’s FA Score: 0 green, 5 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARTV and AURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 4 bullish, 6 bearish.
  • AURA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а -10.43% price change this week, while AURA (@Biotechnology) price change was -9.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.03%. For the same industry, the average monthly price growth was -2.51%, and the average quarterly price growth was +2.77%.

Reported Earning Dates

ARTV is expected to report earnings on Aug 27, 2026.

AURA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($743M) has a higher market cap than ARTV($334M). ARTV YTD gains are higher at: 60.140 vs. AURA (26.697). ARTV has higher annual earnings (EBITDA): -89.43M vs. AURA (-117.51M). AURA has more cash in the bank: 115M vs. ARTV (86.8M). ARTV has less debt than AURA: ARTV (10.3M) vs AURA (17M). ARTV (0) and AURA (0) have equivalent revenues.
ARTVAURAARTV / AURA
Capitalization334M743M45%
EBITDA-89.43M-117.51M76%
Gain YTD60.14026.697225%
P/E RatioN/AN/A-
Revenue00-
Total Cash86.8M115M75%
Total Debt10.3M17M61%
TECHNICAL ANALYSIS
Technical Analysis
ARTVAURA
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 28 days ago
89%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICIEX24.40N/A
N/A
Nomura Core Equity Fund Class I
MEICX50.74N/A
N/A
MFS Value C
GSXPX70.41N/A
N/A
Goldman Sachs Small Cp Val Insghts P
MCECX21.28N/A
N/A
ClearBridge Emerging Markets C
BIAYX12.07N/A
N/A
Brown Advisory Sustainable Sml-Cp Cr Inv

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with RANI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then RANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
-7.91%
RANI - ARTV
45%
Loosely correlated
-4.48%
RADX - ARTV
42%
Loosely correlated
-4.27%
CELC - ARTV
34%
Loosely correlated
-25.66%
AURA - ARTV
32%
Poorly correlated
-3.96%
IRON - ARTV
32%
Poorly correlated
-5.52%
More